Managing bone mineral disorders in CKD: an overview of current therapies

J Ren Care. 2009 Mar:35 Suppl 1:107-10. doi: 10.1111/j.1755-6686.2009.00061.x.
No abstract available

MeSH terms

  • Algorithms
  • Biomarkers / blood
  • Calcitriol / economics
  • Calcitriol / therapeutic use
  • Calcium / blood
  • Chelating Agents / economics
  • Chelating Agents / therapeutic use
  • Chronic Kidney Disease-Mineral and Bone Disorder / diagnosis
  • Chronic Kidney Disease-Mineral and Bone Disorder / etiology
  • Chronic Kidney Disease-Mineral and Bone Disorder / metabolism
  • Chronic Kidney Disease-Mineral and Bone Disorder / therapy*
  • Decision Trees
  • Humans
  • Hyperphosphatemia / diagnosis
  • Hyperphosphatemia / etiology
  • Hyperphosphatemia / metabolism
  • Hyperphosphatemia / therapy*
  • Kidney Failure, Chronic / complications*
  • Nephrology / methods*
  • Nephrology / standards
  • Parathyroid Hormone / blood
  • Parathyroidectomy
  • Patient Care Team
  • Patient Education as Topic
  • Phosphorus / blood
  • Practice Guidelines as Topic
  • Sensitivity and Specificity
  • Treatment Outcome
  • Vitamin D / analogs & derivatives

Substances

  • Biomarkers
  • Chelating Agents
  • Parathyroid Hormone
  • Vitamin D
  • Phosphorus
  • Calcitriol
  • Calcium